ZebraEye

ZebraEye

软件开发

Artificial Intelligence (AI) medical technology company

关于我们

ZebraEye is an artificial intelligence (AI) medical technology company. ZebraEye's first product, the Rare Eye Pathology Screening System, is a proven AI technology for autonomous detection of Fuchs Endothelial Corneal Dystrophy (FECD). ZebraEye's mission is to provide accurate, timely diagnosis of rare eye-threatening diseases that are difficult to detect.

网站
https://zebraeye.ai/
所属行业
软件开发
规模
11-50 人
总部
Palo Alto
类型
私人持股
创立
2023

地点

ZebraEye员工

动态

相似主页

融资